In vitro and in vivo degradation of poly(D, L -lactide-co-glycolide)/ amorphous calcium phosphate copolymer coated on metal stents

Journal of Biomedical Materials Research - Part A

Volumn 96 A, Issue 4, 2011, Pages 632-638

  Ma, Xiaodong ^a,b   Oyamada, Shizu ^c   Wu, Tim ^a,b   Robich, Michael P ^c   Wu, Hao ^b   Wang, Xingwei ^a   Buchholz, Bryan ^a   McCarthy, Stephen ^a   Bianchi, Cesario F ^c   Sellke, Frank W ^c   Laham, Roger ^d  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b VasoTech Inc   (United States)

^c BROWN UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

amorphous calcium phosphate; degradation; poly(D, L lactide co glycolide); stent

Indexed keywords

AMORPHOUS CALCIUM PHOSPHATE; COATED STENTS; DEGRADATION PROFILES; DEGRADATION RATE; DRUG-ELUTING STENTS; IN-VITRO; IN-VIVO; METAL STENTS; MICROSCOPIC OBSERVATIONS; MORPHOLOGICAL CHANGES; PHOSPHATE-BUFFERED SALINES; POLY(D, L -LACTIDE-CO-GLYCOLIDE); POLYMER WEIGHTS; POST-IMPLANTATION; STENT;

BIODEGRADABLE POLYMERS; CALCIUM; DEGRADATION; ORGANIC POLYMERS; PHOSPHATES; PLASTIC COATINGS;

CALCIUM PHOSPHATE;

BUFFER; CALCIUM PHOSPHATE; COPOLYMER; METAL; POLYGLACTIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; AORTA; ARTICLE; DEGRADATION; DRUG ELUTING STENT; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; NONHUMAN; RAT; SURFACE PROPERTY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; DRUG-ELUTING STENTS; LACTIC ACID; MATERIALS TESTING; METALS; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79551689416     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33016     Document Type: Article

References (43)

1. Schofer J, Schlüter M, Gershlick AH, Wijns W, García E, Schampaert E, Breithardt G,. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-1099.
2. Muramatsu T, Tsukahara R, Ho M, Ito Y, Ishimori H, Hirano K, Nakano M, Matsushita M, Leung W,. Clinical outcome of stent implantation in small coronary arteries using different type of coronary stents. J Invasive Cardiol 2001; 13: 634-639.
3. Iijima R, Ikari Y, Miyazawa A, Nakajima H, Hara K,. Predictors of restenosis after implantation of 2.5 mm stents in small coronary arteries. Circ J 2004; 68: 236-240.
4. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A,. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
5. Ong ATL, McFadden EP, Regar E, De Jaegere PPT, Van Domburg RT, Serruys PW,. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-2092.
6. Ong ATL, Hoye A, Aoki J, Van Mieghem CAG, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, Van Der Giessen WJ, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947-953.
7. McFadden EP, Stabile E, Regar E, Cheneau E, Ong ATL, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM,. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521. (Pubitemid 39410418)
8. Tanabe K, Regar E, Regar E, Lee CH, Smits PC, van-der-Giessen WJ,. Sirolimus-eluting stent for treatment of in-stentrestenosis: One-year angiographic and intravascular ultrasound follow-up. J Am Coll Cardiol Suppl A 2003; 41: 12A.
9. Grube E, Silber S,. Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003; 107: 38-42.
10. Eisenberg MJ, Babapulle MN,. Coated stents for the prevention of restenosis. I. Circulation 2002; 106: 2734-2740.
11. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD,. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious? Circulation 2004; 109: 701-705.
12. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R,. Pathology of drug-eluting stents in humans delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
13. Gunatillake PA, Adhikari R,. Biodegradable synthetic polymers for tissue engineering. Eur Cells Mater 2003; 5: 1-16.
14. Hollinger JO,. Preliminary report on the osteogenic potential of a biodegradable copolymer of polyactide (PLA) and polyglycolide (PGA). J Biomed Mater Res 1983; 17: 71-82.
15. Heller J,. Chemically self-regulated drug delivery systems. J Control Release 1988; 8: 111-125.
16. Daniels AU, Chang MKO, Andriano KP, Heller J,. Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone. J Appl Biomater 1990; 1: 57-78.
17. Langer R, Vacanti JP,. Tissue engineering. Science 1993; 260: 920-926.
18. Fraser RK, Cole WG,. Osteolysis after biodegradable pin fixation of fractures in children. J Bone Joint Surg Br 1992; 74: 929-930.
19. Middleton JC, Tipton AJ,. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 2000; 21: 2335-2346.
20. Iwasaki Y, Sawada S-I, Ishihara K, Khang G, Lee HB,. Reduction of surface-induced inflammatory reaction on PLGA/MPC polymer blend. Biomaterials 2002; 23: 3897-3903.
21. Loo SCJ, Ooi CP, Boey YCF,. Radiation effects on poly(lactide-co- glycolide) (PLGA) and poly(-lactide) (PLLA). Polym Degrad Stab 2004; 83: 259-265.
22. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HMM, Serruys PW, Holmes DR, Ellis SG, Topol EJ,. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690-1697.
23. Amjad Z,. Calcium Phosphates in Biological and Industrial Systems. Boston: Kluwer Academic Publishers, 1998.
24. Skrtic D, Antonucci JM, Eanes ED,. Amorphous calcium phosphate-based bioactive polymeric composites for mineralized tissue regeneration. J Res Natl Inst Stand Technol 2003; 108: 167-182.
25. Park M, Eanes E, Antonucci J, Skrtic D,. Mechanical properties of bioactive amorphous calcium phosphate/methacrylate composites. Dent Mater 1998; 14: 137-141.
26. Stamboulis A, Hench LL, Boccaccini AR,. Mechanical properties of biodegradable polymer sutures coated with bioactive glass. J Mater Sci Mater Med 2002; 13: 843-848.
27. CatÄker E, GuemueÅderelioÄlu M, Guener A,. Degradation of PLA. PLGA homo- and copolymers in the presence of serum albumin: A spectroscopic investigation. Polym Int 2000; 49: 728-734.
28. Park TG,. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials 1995; 16: 1123-1130.
29. Yuan X, Mak AFT, Yao K,. In vitro degradation of poly(L- lactic acid) fibers in phosphate buffered saline. J Appl Polym Sci 2001; 85: 936-943.
30. Zhu JH, Shen ZR, Wu LT, Yang SL,. In vitro degradation of polylactide and poly(lactide-co-glycolide) microspheres. J Appl Polym Sci 1991; 43: 2099-2106.
31. Navarro M, Ginebra MP, Planell JA, Barrias CC, Barbosa MA,. In vitro degradation behavior of a novel bioresorbable composite material based on PLA and a soluble CaP glass. Acta Biomater 2005; 1: 411-419.
32. Gao Y, Weng W, Cheng K, Du P, Shen G, Han G, Guan B, Yan W,. Preparation, characterization and cytocompatibility of porous ACP/PLLA composites. J Biomed Mater Res A 2006; 79: 193-200.
33. Furukawa T, Matsusue Y, Yasunaga T, Shikinami Y, Okuno M, Nakamura T,. Biodegradation behavior of ultra-high-strength hydroxyapatite/poly (-lactide) composite rods for internal fixation of bone fractures. Biomaterials 2000; 21: 889-898. (Pubitemid 30114329)
34. Burg KJL, Shalaby SW,. Physicochemical changes in degrading polylactide films. J Biomater Sci Polym Ed 1997; 9: 15-29.
35. Tracy MA, Ward KL, Firouzabadian L, Wang Y, Dong N, Qian R, Zhang Y,. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 1999; 20: 1057-1062.
36. Menei P, Daniel V, Montero-Menei C, Brouillard M, Pouplard-Barthelaix A, Benoit JP,. Biodegradation and brain tissue reaction to poly [D L-lactide-co-glycolide] microspheres. Biomaterials 1993; 14: 470-478.
37. Ali SA, Doherty PJ, Williams DF,. Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo. Biomaterials 1994; 15: 779-785.
38. Williams DF, Mort E,. Enzyme-accelerated hydrolysis of polyglycolic acid. J Bioeng 1977; 1: 231-238.
39. Tokiwa Y, Suzuki T,. Hydrolysis of polyesters by lipases. Nature 1977; 270: 76-78.
40. Waksman R,. Biodegradable stents: They do their job and disappear. J Invasive Cardiol 2006; 18: 70-74.
41. Nakazawa G, Finn AV, Kolodgie FD, Virmani R,. A review of current devices and a look at new technology: Drug-eluting stents. Expert Rev Med Devices 2009; 6: 33-42.
42. Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carrie D, Thuesen L,. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: The SPIRIT II trial. EuroIntervention 2006; 2: 286-294.
43. Kandzari DE, Leon MB,. Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent. J Interv Cardiol 2006; 19: 405-413.